The presence of RA-specific autoantibodies, IgM-rheumatoid factor (RF), and anti-citrullinated protein antibodies (ACPA), in a large percentage of patients is a hallmark of RA [6]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.